Various central nervous system (CNS) targets

The term 'Various central nervous system (CNS) targets' is a non-specific descriptor used to categorize therapeutic agents that interact with a wide array of molecular sites within the brain and spinal cord [1]. This designation is typically applied to drugs with complex polypharmacological profiles, such as certain antipsychotics or antidepressants, where the therapeutic effect is derived from the simultaneous modulation of multiple receptors, transporters, or enzymes [2]. Because it does not identify a single protein or pathway, it is considered an aggregate category rather than a distinct, valid therapeutic target in molecular biology [3]. In drug development, this classification often reflects the challenge of treating multifaceted neurological conditions that require broad-spectrum engagement of the nervous system [4]. Consequently, while useful for high-level grouping, it lacks the precision required for precise drug-target interaction studies or targeted molecular design [5]. Biotech analysts should interpret this term as an indication of a multi-target mechanism of action rather than a singular biological entity [6].

Other names

CNS targetsMultiple CNS targetsVarious CNS receptorsCentral nervous system targets

Polypharmacological modulation of multiple central nervous system receptors, transporters, and enzymes.